Social prescribing for people living with dementia (PLWD) and their carers: what works, for whom, under what circumstances and why – protocol for a complex intervention systematic review

IntroductionDementia is a complex medical condition that poses significant challenges to healthcare systems and support services. People living with dementia (PLWD) and their carers experience complex needs often exacerbated by social isolation and challenges in accessing support. Social prescribing...

Full description

Saved in:
Bibliographic Details
Published inBMJ open Vol. 14; no. 4; p. e080551
Main Authors Marshall, Jessica, Papavasiliou, Evie, Fox, Chris, Hawkes, Matthew, Irvine, Anne, Moniz-Cook, Esme, Pick, Aimee, Polley, Marie J, Reeve, Joanne, Robinson, Louise, Rook, George, Sadler, Euan, Wolverson, Emma, Walker, Sarah, Cross, Jane L, Cross, Jane, Allan, Louise, Avery, Anthony, Bradbury, Katherine, Medina-Lara, Antonieta, Morrish, Nia, Orrell, Martin, Poland, Fiona, Polley, Marie, Rathbone, Amy, Robinson, Dame Louise, Samsi, Kritika, Shepstone, Lee
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 08.04.2024
BMJ Publishing Group LTD
BMJ Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:IntroductionDementia is a complex medical condition that poses significant challenges to healthcare systems and support services. People living with dementia (PLWD) and their carers experience complex needs often exacerbated by social isolation and challenges in accessing support. Social prescribing (SP) seeks to enable PLWD and their carers to access community and voluntary sector resources to support them address such needs. Existing research, however, does not describe what SP interventions are currently in place in dementia care. Little is known about the needs these interventions are designed to address, the reasons that lead PLWD and their carers to participate in them, their effectiveness and the extent to which they could increase positive health outcomes if adopted and how.Methods and analysisA complex intervention systematic review of SP for PLWD and/or their carers will be conducted using an iterative logic model approach. Six electronic (MEDLINE, EMBASE, PsycINFO, CINAHL, Scopus and Cochrane/CENTRAL) and two grey literature databases (EThOS and CORE) were searched for publications between 1 January 2003 and June 2023, supplemented by handsearching of reference lists of included studies. Study selection, data extraction and risk of bias assessment, using Gough’s Weight of Evidence Framework, will be independently performed by two reviewers. A narrative approach will be employed to synthesise and report quantitative and qualitative data. Reporting will be informed by the Preferred Reporting Items for Systematic Review and Meta-Analysis Complex Interventions extension statement and checklist.Ethics and disseminationNo ethical approval is required due to this systematic review operating only with secondary sources. Findings will be disseminated through peer-reviewed publications, conference presentations and meetings with key stakeholders including healthcare professionals, patient and carer groups, community organisations (eg, the Social Prescribing Network and the Evidence Collaborative at the National Academy for Social Prescribing), policymakers and funding bodies.PROSPERO registration numberCRD42023428625.
Bibliography:Protocol
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2044-6055
2044-6055
DOI:10.1136/bmjopen-2023-080551